270 related articles for article (PubMed ID: 35687217)
21. Protective role of microRNA-27a upregulation and HSP90 silencing against cerebral ischemia-reperfusion injury in rats by activating PI3K/AKT/mTOR signaling pathway.
Zhang E; Chen Q; Wang J; Li D; Wan Z; Ju X
Int Immunopharmacol; 2020 Sep; 86():106635. PubMed ID: 32634698
[TBL] [Abstract][Full Text] [Related]
22. Mangiferin ameliorates placental oxidative stress and activates PI3K/Akt/mTOR pathway in mouse model of preeclampsia.
Huang J; Zheng L; Wang F; Su Y; Kong H; Xin H
Arch Pharm Res; 2020 Feb; 43(2):233-241. PubMed ID: 31989480
[TBL] [Abstract][Full Text] [Related]
23. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release.
Russo E; Andreozzi F; Iuliano R; Dattilo V; Procopio T; Fiume G; Mimmi S; Perrotti N; Citraro R; Sesti G; Constanti A; De Sarro G
Brain Behav Immun; 2014 Nov; 42():157-68. PubMed ID: 24998197
[TBL] [Abstract][Full Text] [Related]
24. Aluminum-Induced Cognitive Impairment and PI3K/Akt/mTOR Signaling Pathway Involvement in Occupational Aluminum Workers.
Shang N; Zhang P; Wang S; Chen J; Fan R; Chen J; Huang T; Wang Y; Duncan J; Zhang L; Niu Q; Zhang Q
Neurotox Res; 2020 Aug; 38(2):344-358. PubMed ID: 32506341
[TBL] [Abstract][Full Text] [Related]
25. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress.
Mirza R; Sharma B
Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919
[TBL] [Abstract][Full Text] [Related]
26. Taurine Improved Autism-Like Behaviours and Defective Neurogenesis of the Hippocampus in BTBR Mice through the PTEN/mTOR/AKT Signalling Pathway.
Xiaoyan H; Zhaoxi Y; Lingli Z; Jinyuan C; Wen Q
Folia Biol (Praha); 2024; 70(1):45-52. PubMed ID: 38830122
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of DDIT4 ameliorates abnormal behaviors in autism by inhibiting ferroptosis via the PI3K/Akt pathway.
Luo T; Chen SS; Ruan Y; Chen HY; Chen YM; Li YM; Zhou W
Biochem Biophys Res Commun; 2023 Jan; 641():168-176. PubMed ID: 36528956
[TBL] [Abstract][Full Text] [Related]
28. Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat.
Amini-Khoei H; Saghaei E; Mobini GR; Sabzevary-Ghahfarokhi M; Ahmadi R; Bagheri N; Mokhtari T
Neuropeptides; 2019 Oct; 77():101942. PubMed ID: 31272684
[TBL] [Abstract][Full Text] [Related]
29. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway.
Hou X; Hu Z; Xu H; Xu J; Zhang S; Zhong Y; He X; Wang N
Cardiovasc Diabetol; 2014 Apr; 13():78. PubMed ID: 24725502
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of the effect of TREM2 on cognitive function in autistic mice.
Tian Y; Ai R; Xiao X; Liu W; Cheng S; Zhu X
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):66-72. PubMed ID: 38836680
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders.
Bhandari R; Kuhad A
Neurochem Int; 2017 Feb; 103():8-23. PubMed ID: 28025035
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil contributes to downregulation of the hippocampal interleukin type 2 and 1β mediated PI3K/AKT/mTOR pathway hyperactivation and attenuates neurobehavioral comorbidities in a rat model of temporal lobe epilepsy.
Mazumder AG; Patial V; Singh D
Brain Behav Immun; 2019 Jan; 75():84-93. PubMed ID: 30243822
[TBL] [Abstract][Full Text] [Related]
33. Role of PI3K/AKT/mTOR Pathway Associated Oxidative Stress and Cardiac Dysfunction in Takotsubo Syndrome.
Mao S; Luo X; Li Y; He C; Huang F; Su C
Curr Neurovasc Res; 2020; 17(1):35-43. PubMed ID: 31870264
[TBL] [Abstract][Full Text] [Related]
34. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis.
Xue JF; Shi ZM; Zou J; Li XL
Biomed Pharmacother; 2017 May; 89():1252-1261. PubMed ID: 28320092
[TBL] [Abstract][Full Text] [Related]
36. Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.
Lim HJ; Crowe P; Yang JL
J Cancer Res Clin Oncol; 2015 Apr; 141(4):671-89. PubMed ID: 25146530
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effect of ginkgetin in experimental cerebral ischemia/reperfusion via apoptosis inhibition and PI3K/Akt/mTOR signaling pathway activation.
Tian Z; Tang C; Wang Z
J Cell Biochem; 2019 Oct; 120(10):18487-18495. PubMed ID: 31265179
[TBL] [Abstract][Full Text] [Related]
38. Trametenolic acid B protects against cerebral ischemia and reperfusion injury through modulation of microRNA-10a and PI3K/Akt/mTOR signaling pathways.
Wang J; Wang A; He H; She X; He Y; Li S; Liu L; Luo T; Huang N; Luo H; Zou K
Biomed Pharmacother; 2019 Apr; 112():108692. PubMed ID: 30798122
[TBL] [Abstract][Full Text] [Related]
39. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
40. Behavioural and brain ultrastructural changes following the systemic administration of propionic acid in adolescent male rats. Further development of a rodent model of autism.
Lobzhanidze G; Japaridze N; Lordkipanidze T; Rzayev F; MacFabe D; Zhvania M
Int J Dev Neurosci; 2020 Apr; 80(2):139-156. PubMed ID: 31997401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
